ArticleJournal of clinical laboratory analysis2026
Prolonged Turnaround Time of the Hematology Laboratory and Related Factors in the South Gondar Zone, North West Ethiopia, Multi-Centered Study.
Article in Journal of clinical laboratory analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTurnaround time refers to the time it takes from receiving a sample in the lab to delivering test results to clinicians or stakeholders. This study aimed to determine the magnitude of prolonged turnaround time in the hematology laboratory of three selected hospitals in the South Gondar zone, North West Ethiopia. METHODOLOGY: An institutional-based cross-sectional study was conducted from September to December 2023 in the hematology laboratory of selected South Gondar zone hospitals. Debre Tabor's Comprehensive Specialized Hospital was selected purposefully as the sole referral hospital, while Addis Zemen and Nefas Mewcha primary hospitals were randomly selected. The final sample size was 2401. Missing values (n = 70) were managed using the deletion method, assuming data were Missing completely at Random (MCAR). The final dataset included 2331 dataset.
resultOf the 2331 samples, 807 (34.6%: 95% CI 32.8%-36.6%) had prolonged turnaround time. Poor sample condition caused delays in 382 (16.4%) samples. Workday of the weeks, clotted blood samples, and blood fill levels were significantly associated with prolonged TAT.
conclusionThe magnitude of prolonged TAT in hematology laboratories is high. The delays are primarily driven by preanalytical factors, specifically poor sample condition (clotting and improper fill levels) and timing of collection (Fridays). Interventions should focus on enhancing preanalytical sample quality management and optimizing laboratory workflows to reduce prolonged TAT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.